Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients

BACKGROUND: There is a growing body of evidence that immune response plays a large role in cancer outcome. The neutrophil to lymphocyte ratio (NLR) has been used as a simple parameter of systemic inflammation in several tumors. The purpose was to investigate the association between pre-treatment NLR...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Pistelli, Mirco, De Lisa, Mariagrazia, Ballatore, Zelmira, Caramanti, Miriam, Pagliacci, Alessandra, Battelli, Nicola, Ridolfi, Francesca, Santoni, Matteo, Maccaroni, Elena, Bracci, Raffaella, Santinelli, Alfredo, Biscotti, Tommasina, Berardi, Rossana, Cascinu, Stefano
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4428113/
https://ncbi.nlm.nih.gov/pubmed/25884918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1204-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars